Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

05 juil. 2017 08h30 HE | Source: Marina Biotech, Inc.

Marina Biotech Announces the Appointment of Dr. Vuong Trieu as Executive Chairman

CITY OF INDUSTRY, CA--(Marketwired - Jul 5, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
26 juin 2017 08h30 HE | Source: Marina Biotech, Inc.

Marina Biotech Appoints Chief Commercial Officer to Lead Sales and Marketing of Prestalia(R)

CITY OF INDUSTRY, CA--(Marketwired - Jun 26, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
06 juin 2017 08h30 HE | Source: Marina Biotech, Inc.

Marina Biotech Acquires Prestalia(R), a U.S. FDA Approved Drug for Patients Whose Blood Pressure Is Not Adequately Controlled by Monotherapy

CITY OF INDUSTRY, CA--(Marketwired - Jun 6, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
30 mai 2017 08h45 HE | Source: Marina Biotech, Inc.

Marina Biotech to Introduce Its Therapeutic Microbiome Programs Against Gastrointestinal Diseases

CITY OF INDUSTRY, CA--(Marketwired - May 30, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
27 avr. 2017 14h00 HE | Source: Marina Biotech, Inc.

Marina Biotech to Participate in Joseph Gunnar's Pioneers 2017 Conference on May 2

CITY OF INDUSTRY, CA--(Marketwired - Apr 27, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
05 avr. 2017 08h45 HE | Source: Marina Biotech, Inc.

Marina Biotech Provides Business Update

CITY OF INDUSTRY, CA--(Marketwired - Apr 5, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative...
03 avr. 2017 09h00 HE | Source: Marina Biotech, Inc.

Marina Biotech Signs Definitive Agreement with Windlas Healthcare to Manufacture IT-102 FDC Bi-Layer Tablet

CITY OF INDUSTRY, CA--(Marketwired - Apr 3, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
29 mars 2017 09h05 HE | Source: Marina Biotech, Inc.

Marina Biotech to Present Data on IT-102 and IT-103 at 2017 American Association for Cancer Research Annual Meeting

CITY OF INDUSTRY, CA--(Marketwired - Mar 29, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
24 mars 2017 09h10 HE | Source: Marina Biotech, Inc.

Marina Biotech to Present Data on Vascular Resistance and Cancer at the Endocrine Society Annual Meeting on April 1

CITY OF INDUSTRY, CA--(Marketwired - Mar 24, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
13 mars 2017 09h05 HE | Source: Marina Biotech, Inc.

Marina Biotech to Present A Late Breaking Poster on the Safety and Tolerability of CEQ508 for FAP at the Society of Toxicology 56th Annual Meeting on March 16

CITY OF INDUSTRY, CA--(Marketwired - Mar 13, 2017) - Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...

Page suivante